Brian D. Lu
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 18
- Pancreatic and Hepatic Oncology Research 15
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- David B Goldstein (8 shared papers)Daniel D. Von Hoff (9 shared papers)Josep M. Tabernero (7 shared papers)Volker Kunzmann (4 shared papers)Alfredo Romano (2 shared papers)Robert Hassan El-Maraghi (2 shared papers)Giampaolo Tortora (2 shared papers)Salvatore Siena (2 shared papers)
- Journals
- Annals of Oncology (7 papers)The Journal of Cell Biology (2 papers)Pancreas (2 papers)Open Forum Infectious Diseases (2 papers)Developmental Biology (1 paper)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Brian D. Lu
41 papers receiving 1.7k citations
Brian D. Lu's Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 943
- Cancer Research 302
- Molecular Biology 525
- Pulmonary and Respiratory Medicine 223
- Surgery 216
Countries citing papers authored by Brian D. Lu
This map shows the geographic impact of Brian D. Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian D. Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian D. Lu more than expected).
Fields of papers citing papers by Brian D. Lu
This network shows the impact of papers produced by Brian D. Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian D. Lu. The network helps show where Brian D. Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian D. Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial Hit paper breakdown → | 2015 | 565 |
| 2 | 2022 | 104 | |
| 3 | 2020 | 102 | |
| 4 | 2020 | 92 | |
| 5 | 2016 | 91 | |
| 6 | 1998 | 90 | |
| 7 | 2016 | 83 | |
| 8 | 2016 | 79 | |
| 9 | 1997 | 78 | |
| 10 | 1999 | 46 | |
| 11 | 2015 | 46 | |
| 12 | 2015 | 45 | |
| 13 | 2020 | 39 | |
| 14 | 2021 | 38 | |
| 15 | 2016 | 38 | |
| 16 | 2016 | 24 | |
| 17 | 2018 | 22 | |
| 18 | 2017 | 22 | |
| 19 | 2017 | 22 | |
| 20 | 2014 | 20 |
About Brian D. Lu
Brian D. Lu is a scholar working on Oncology, Cancer Research, Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology, having authored 42 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (15 papers), Pancreatic function and diabetes (6 papers), Cancer Genomics and Diagnostics (4 papers), Diabetes and associated disorders (4 papers), Muscle Physiology and Disorders (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Cardiomyopathy and Myosin Studies (3 papers) and Fungal Infections and Studies (2 papers). The work is most often cited by research in Oncology (943 citations), Cancer Research (302 citations), Molecular Biology (525 citations), Pulmonary and Respiratory Medicine (223 citations) and Surgery (216 citations). Brian D. Lu has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include David B Goldstein, Daniel D. Von Hoff, Josep M. Tabernero, Volker Kunzmann, Alfredo Romano, Robert Hassan El-Maraghi, Giampaolo Tortora, Salvatore Siena, Jean‐Luc Van Laethem and Luís Teixeira. Their work appears in journals such as Annals of Oncology, The Journal of Cell Biology, Pancreas, Open Forum Infectious Diseases and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.